Company Analysis
Sign in

GE HealthCare Technologies Inc. (GEHC)

Nasdaq: GEHC · X-Ray Apparatus & Tubes & Related Irradiation Apparatus · Chicago, IL · filing with the SEC since 2022
Full chart Alerts Compare
Grade6.0
◀ Past 7.2● Present 5.9▶ Future 4.9
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

The grade of GE HealthCare Technologies Inc.

Nine metrics read from its own filings, by tense
Headline grade
6.0/10
◀ Past7.230% of the headline
● Present5.940% of the headline
▶ Future4.930% of the headline

All three tenses have at least two readings, so the archetype blend applies as printed.

Of the nine metrics, 8 read as filed from the record and 1 is an SI estimate, each with its reasoning, its confidence and what would change it on its card.

◀ Past

What did they actually do?

7.2/1030% of the headline grade · 3 of 3 filed

Surviving crises

as filed
7.5/10

Has it survived what it has been through?

No warning events in its filings since 2022.

weight 33% of this tense · 75th percentile among 24 sector filers · read for itself

From the record

GE HealthCare Technologies Inc.'s filings since 2022 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Track record

as filed
8.2/10

What has it actually done, year after year?

+4.1% a year over 5 filed years; profitable in 5 of 5.

weight 45% of this tense · 82nd percentile among 23 sector filers · read for its customers

From the record

GE HealthCare Technologies Inc.'s 5 filed years say what it did: revenue went from $18 billion in fiscal 2021 to $21 billion in fiscal 2025, up 4.1% a year; it rose in 4 of 4 years; it never fell from a peak; net income was positive in 5 of 5 of those years (its annual reports).

What it rests on

  • revenue growth over the filed span4.1%top 46% of its family
  • the share of years revenue rosetop 4% of its family
  • the share of filed years with a profittop 17% of its family
  • the deepest fall from a revenue peak0.0%top 4% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Shareholder treatment

as filed
4.7/10

How has it treated the people who own it?

Share count grew 0.3% a year. 6% of cash flow returned. Insiders: 0 sales, 8 purchases.

weight 22% of this tense · 47th percentile among 16 sector filers · read for its shareholders

From the record

Over the 3 fiscal years to 2025-12-31, GE HealthCare Technologies Inc.'s diluted share count grew about 0.3% a year, and dividends and buybacks returned about 6% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 0 sales and 8 purchases of their own stock on the open market in the year to 2026-09-30, buying about $6 million (their Form 4 filings).

What it rests on

  • the share count over the yearsbottom 48% of its family
  • cash returned against operating cash flowbottom 47% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

● Present

What are they doing right now?

5.9/1040% of the headline grade · 2 of 3 filed, 1 estimated

Financial health

as filed
5.0/10

Is it financially healthy right now?

ROE 20%: 20¢ of profit per shareholder dollar. Leverage 72%: owes 72¢ per asset dollar.

weight 45% of this tense · 50th percentile among 24 sector filers · read for itself

From the record

Return on equity: in the fiscal year ended 2025-12-31, GE HealthCare Technologies Inc. earned about 20 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 22 cents per dollar of everything the company owns. Leverage: it owed about 72 cents per dollar of assets, and net share issuance: its share count shrank 0.2% over the year (the filed statements).

What it rests on

  • what it owes per dollar of assetsbottom 15% of its family
  • return on equitytop 23% of its family
  • gross profit against assetsbottom 33% of its family
  • the share count against the year beforetop 23% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Industry position

as filed
6.9/10

How strong is its position in its industry?

top 31% of 23 in its family; net margin 10.1%.

weight 33% of this tense · 69th percentile among 23 sector filers · read for its customers

From the record

GE HealthCare Technologies Inc.'s standing among 23 graded names in its industry family: revenue of $21 billion in fiscal 2025 ranks in the top 7% by size; a net margin of 10.1% ranks in the top 37%; revenue growth of 4% a year over the last 3 filed years ranks in the top 50% (its annual reports).

What it rests on

  • revenue against the family$20.63Btop 7% of its family
  • net margin10.1%top 37% of its family
  • three-year revenue growth4.0%top 50% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Leadership

SI estimate
6.0/10

What are the people in charge doing?

SI estimate 6.0/10, confidence 35 of 100 (one part).

weight 22% of this tense · 61st percentile among 19 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate
Read from one part only, officer and director changes on Form 8-K over three years, against the people in charge, which ranks in the top 39% of 19 in its family; the record of its people begins on 2022-12-08 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 3.9 years and cannot see past it; a floor under five years is not read as years in charge.
What the record cannot read
The record of its people begins on 2022-12-08 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 3.9 years and cannot see past it; a floor under five years is not read as years in charge.
How it was reasoned
one part: officer and director changes on Form 8-K, against the people in charge, the one part on file, ranked among 19 in its family.
Confidence
35 of 100
What would change it
A filing that carries the missing parts replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: GE HealthCare Technologies Inc.'s leadership is put at 6.0 of 10 with a confidence of 35 of 100, because read from one part only, officer and director changes on Form 8-K over three years, against the people in charge, which ranks in the top 39% of 19 in its family; the record of its people begins on 2022-12-08 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 3.9 years and cannot see past it; a floor under five years is not read as years in charge. A filing that carries the missing parts replaces this estimate with the filed reading.

▶ Future

What are they set up to do next?

4.9/1030% of the headline grade · 3 of 3 filed

Room to expand

as filed
4.2/10

How much room does it have to grow?

bottom 42% of 23 in its family for room to expand.

weight 45% of this tense · 42nd percentile among 23 sector filers · read for itself

From the record

GE HealthCare Technologies Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $4.5 billion against debt of $10 billion leaves -14.9% of its assets as net cash, bottom 21% of its family; cash from operations less capital spending is 7.3% of revenue (bottom 48%); a gross margin of 40% (bottom 43%); research spending of 6.1% of revenue (top 42%) (its annual report).

What it rests on

  • cash less debt against assets-14.9%bottom 21% of its family
  • cash from operations less capital spending against revenue7.3%bottom 48% of its family
  • gross margin40.0%bottom 43% of its family
  • research spending against revenue6.1%top 42% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Growth drivers

as filed
6.3/10

What could actually drive growth from here?

top 37% of 23 in its family for growth drivers.

weight 33% of this tense · 63rd percentile among 23 sector filers · read for its customers

From the record

GE HealthCare Technologies Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 4% a year over the last three filed years against 4.1% over all 5, slowing (top 41% of its family); the newest year grew 4.8% (bottom 46%); research spending grew 7.1% a year (top 29%); capital spending grew 15.8% a year (top 24%) (its annual reports). GE HealthCare Technologies Inc. reported 2 product lines in fiscal 2025: Product at $14 billion (66%), Service at $7.0 billion (34%); 2 of 2 grew against the year before (its annual report).

What it rests on

  • three-year growth against the whole span-0.1 points a yeartop 41% of its family
  • the newest year's revenue growth4.8%bottom 46% of its family
  • three-year growth of research spending7.1%top 29% of its family
  • three-year growth of capital spending15.8%top 24% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Expectations vs reality

as filed
4.0/10

Did its newest year beat what its own record pointed to?

bottom 40% of 22 in its family for expectations against reality.

weight 22% of this tense · 40th percentile among 22 sector filers · read for its shareholders

From the record

GE HealthCare Technologies Inc.'s newest year against its own record: revenue of $21 billion in fiscal 2025 came in 1.2% above the $20 billion its prior three years' pace pointed to (bottom 48% of its family); net income of $2.1 billion against a prior three-year average of $1.8 billion (bottom 39%); a net margin of 10.1% against 9.5% before (bottom 34%) (its annual reports).

What it rests on

  • revenue against the prior three years' pace1.2%bottom 48% of its family
  • net income against the prior three years' average+14%bottom 39% of its family
  • net margin against its prior average+0.6 pointsbottom 34% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made

SI Assistanton GEHC · research, not advice